Qube Research & Technologies LTD Harpoon Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.94 - $2.56 $1,789 - $4,874	-1,904 Reduced 11.34%	14,892 $14,000
Q2 2022 Aug 15, 2022	BUY	$1.78 - $5.02 $29,896 - $84,315	16,796 New	16,796 $32,000
Q4 2021 Feb 01, 2022	SELL	$5.69 - $7.83 $255,481 - $351,567	-44,900 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$7.88 - $14.0 $71,936 - $127,806	-9,129 Reduced 16.9%	44,900 $355,000
Q2 2021 Aug 13, 2021	BUY	$13.81 - $23.25 $746,140 - $1.26 Million	54,029 New	54,029 $749,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.